Some researchers have found mRNA is likely passed from an injected human to a noninjected human, and to humans who have consumed meat or dairy products from an mRNA-injected animal.
Following a meeting with medical doctors and a molecular biologist, R-CALF USA Animal Health Committee Chair, Max Thornsberry, DVM, briefed the R-CALF USA board on the status of mRNA injections in the global protein supply. He said this warrants more extensive mRNA research.
While the United States has not approved mRNA injections in cattle, they are in use on a limited basis in swine. Thornsberry said the U.S. is importing more and more beef from many different countries, some of which either already are or plan to begin using mRNA in cattle for such diseases as foot-and-mouth disease and lumpy skin disease.
“This points to the urgent need for MCOOL (mandatory country of origin labeling),” he said. “Consumers deserve the right to choose whether to consume beef from a country where mRNA injections are being given to cattle, and the only way they can have that choice is if Congress passes MCOOL for beef.”
The R-CALF USA board will bring this issue before the membership at its next annual meeting to determine policy direction for the organization.
Until that policy is fully developed, R-CALF USA says it strongly reinforces the need for mandatory country of origin labeling on beef immediately. R-CALF USA President Brett Kenzy said, “Without an MCOOL label on our beef, the American consumer has no way of knowing if the beef they are buying is coming from a country using this debatable mRNA technology in their cattle health management.”
Kenzy pointed out that new information about mRNA vaccines is becoming public at the same time beef imports are increasing and U.S. cattle inventory surpasses 60-year inventory lows. He said the result is that domestic beef demand is becoming more dependent on the global beef supply chain, which makes enactment of MCOOL all the more urgent.
Story via R-CALF Press Release
